Latest Angina pectoris Stories
PALO ALTO, Calif., Aug. 19 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc.
PALO ALTO, Calif., Aug. 14 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. announced today that it has received approval from the European Medicines Agency (EMEA) for the brand name Ranexa(R) (ranolazine).
PALO ALTO, Calif., Aug. 14 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc.
MONTVALE, N.J., June 30, 2008 (PRIME NEWSWIRE) -- Ivivi Technologies, Inc.
U.S. cardiologists have discovered nearly 1-in-5 patients experiences chest pain one year after suffering a heart attack. Dr.
By Ask Dr. Ramo BARRY RAMO For the Journal Three weeks ago, I got a call from the wife of one of my longtime patients telling me that her 60-year-old husband had died suddenly at home while reading the newspaper.
PALO ALTO, Calif., June 23 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc.
St. Jude Medical, Inc. (NYSE:STJ) today announced the first patient implant in a pilot study that will preliminarily evaluate if stimulating nerves near the spinal cord will control chronic chest pain caused by angina.
By Nasir, Javed M; Durning, Steven J; Sweet, Jon M; Cation, Lannie J Chest pain with electrocardiographic changes is usually a life- threatening presentation of cardiac ischemia.
A large number of adults with both high blood pressure and high cholesterol are not receiving treatment, a study shows.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.